中国における小児心不全治療の地理的格差:多施設共同研究
Muhammad Junaid Akram1,2, Yin Yue1,2, Asad Nawaz1,2
1Department of Cardiology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing, China.
Frontiers in public health
|February 2, 2026
まとめ
地理的位置は中国における小児心不全(PHF)の生存率に大きく影響する。西部および中部地域の子供たちは、ケアと疾患の提示における格差により、死亡リスクが高い。
科学分野:
- 心臓病学;公衆衛生;地理空間分析
背景:
- 小児心不全(PHF)は、成人心不全とは異なる特有の課題を提示します。
- 中国には重大な地理的医療格差が存在し、PHF患者の予後に影響を与えています。
- これらの格差がPHF患者のプロファイル、管理、および生存率に与える影響は定量化されていませんでした。
研究 の 目的:
- 地理的位置とPHF患者プロファイルとの関連を体系的に調査する。
- 地理的位置がPHF管理および生存率に与える影響を分析する。
- 地理的医療格差が中国の小児心不全に与える影響を定量化する。
主な方法:
- 一次HF診断を受けた2,903人の小児入院患者の後ろ向き分析(2013年から2022年)。
- 地理的に東部、西部、中部中国のコホートに層別化。
- 交絡因子で調整した院内死亡率の多変量ロジスティック回帰分析。
- 滞在期間のガンマ一般化線形モデル。
主要な成果:
- 西部の患者は若く、先天性心疾患の有病率が高く、臨床状態が重篤でした。
- 心筋症は東部で優勢でした。ガイドライン指向の医学的治療(GDMT)は非東部地域で最も低かったです。
- 地理的地域は死亡率を独立して予測しました:東部と比較して、西部では死亡調整オッズが2.58倍、中国中部では3.54倍高かったです。
結論:
- 地理的位置は、中国の小児心不全患者の生存率の重要な独立した予測因子です。
- 調査結果は、介入の緊急の必要性がある階層的な医療状況を明らかにしています。
- 地域能力構築と標準化された紹介経路を通じて、格差を軽減し、公平なケアを確保するためには、ターゲットを絞った介入が不可欠です。
関連する概念動画
Heart Failure II: Pathophysiology
929
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
Pathophysiology of Heart Failure
3.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction
886
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
Heart Failure VI: Adjunct Therapies
340
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
Heart Failure Drugs: Diuretics
971
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971
Heart Failure V: Medical Management
319
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319


